Publications

Anthony-Gonda K, Bardhi A, Ray A, Flerin N, Li M, Chen W, Ochsenbauer C, Kappes JC, Krueger W, Worden A et al..  2019.  Multispecific anti-HIV duoCAR-T cells display broad in vitro antiviral activity and potent in vivo elimination of HIV-infected cells in a humanized mouse model.. Sci Transl Med. 11(504)

Avila-Rios S, Carlson JM, John M, Mallal S, Brumme ZL.  2019.  Clinical and evolutionary consequences of HIV adaptation to HLA: implications for vaccine and cure.. Curr Opin HIV AIDS. 14(3):194-204.

Bachtel ND, Umviligihozo G, Pickering S, Mota TM, Liang H, Del Prete GQ, Chatterjee P, Lee GQ, Thomas R, Brockman MA et al..  2018.  HLA-C downregulation by HIV-1 adapts to host HLA genotype.. PLoS Pathog. 14(9):e1007257.

Bachtel ND, Beckerle GA, Mota T, Rougvie Mde Mulder, Raposo RAndre, R Jones B, Nixon DF, Apps R.  2018.  Expression of host restriction factors by memory CD4+ T cells differs between healthy donors and HIV-1 infected individuals with effective ART.. AIDS Res Hum Retroviruses.

Bardhi A, Wu Y, Chen W, Li W, Zhu Z, Zheng JHua, Wong H, Jeng E, Jones J, Ochsenbauer C et al..  2017.  Potent NK Cell-Mediated Elimination of HIV-1-Infected Cells Mobilized by a gp120-Bispecific and Hexavalent Broadly Neutralizing Fusion Protein.. J Virol. 91(20)

A Barrett J, Prockop S, Bollard CM.  2018.  Reprint of: Virus-Specific T Cells: Broadening Applicability.. Biol Blood Marrow Transplant. 24(3S):S1-S6.

A Barrett J, Prockop S, Bollard CM.  2018.  Virus-Specific T Cells: Broadening Applicability.. Biol Blood Marrow Transplant. 24(1):13-18.

Bronnimann MP, Skinner PJ, Connick E.  2018.  The B-Cell Follicle in HIV Infection: Barrier to a Cure.. Front Immunol. 9:20.

Clutton GTyndale, R Jones B.  2018.  Diverse Impacts of HIV Latency-Reversing Agents on CD8+ T-Cell Function: Implications for HIV Cure.. Front Immunol. 9:1452.

Cruz CRussell, Bollard CM.  2017.  HIV Receives a "One Two Knockout Punch".. Mol Ther. 25(3):566-567.

Flerin NC, Chen H, Glover TD.  2017.  TCR Clonotype-specific Differences in Inhibitory Activity of HIV-1 Cytotoxic T Cell Clones is Not Mediated by TCR Alone. American Society for Microbiology Journals.

Huang S.H..  2018.  Latent HIV reservoirs exhibit inherent resistance to elimination by CD8+ T cells.. J Clin Invest. 128(2)

Jones R.B..  2017.  Antigen recognition-triggered drug delivery mediated by nanocapsule-functionalized cytotoxic T-cells.. Biomaterials. 117

Jones B.R..  2018.  Phylogenetic approach to recover integration dates of latent HIV sequences within-host.. Proc Natl Acad Sci U S A. 115(38)

Li S..  2016.  Simian Immunodeficiency Virus-Producing Cells in Follicles Are Partially Suppressed by CD8+ Cells In Vivo.. J Virol. 90(24)

Lin X..  2017.  Protein Phosphatase-1 -targeted Small Molecules, Iron Chelators and Curcumin Analogs as HIV-1 Antivirals.. Curr Pharm Des. 23(28)

Lin X..  2017.  Inhibition of HIV-1 infection in humanized mice and metabolic stability of protein phosphatase-1-targeting small molecule 1E7-03. . Oncotarget. 8(44)

Macedo A.B..  2018.  Influence of Biological Sex, Age, and HIV Status in an In Vitro Primary Cell Model of HIV Latency Using a CXCR4 Tropic Virus.. AIDS Res Hum Retroviruses. 34(9)

Macedo AB, Novis CL, De Assis CM, Sorensen ES, Moszczynski P, Huang S-H, Ren Y, Spivak AM, R Jones B, Planelles V et al..  2018.  Dual TLR2 and TLR7 agonists as HIV latency-reversing agents.. JCI Insight. 3(19)

Moroco JA, Alvarado JJeff, Staudt RP, Shi H, Wales TE, Smithgall TE, Engen JR.  2018.  Remodeling of HIV-1 Nef Structure by Src-Family Kinase Binding.. J Mol Biol. 430(3):310-321.

Mujib S..  2017.  Pharmacologic HIV-1 Nef blockade promotes CD8 T cell-mediated elimination of latently HIV-1-infected cells in vitro.. JCI Insight. 2(17)

Osuna CE, Lim S-Y, Kublin JL, Apps R, Chen E, Mota TM, Huang S-H, Ren Y, Bachtel ND, Tsibris AM et al..  2018.  Evidence that CD32a does not mark the HIV-1 latent reservoir.. Nature. 561(7723):E20-E28.

Patel S..  2016.  T-cell therapies for HIV: Preclinical successes and current clinical strategies.. Cytotherapy. 18(8)

Pinzone MRita, O'Doherty U.  2018.  Measuring integrated HIV DNA ex vivo and in vitro provides insights about how reservoirs are formed and maintained.. Retrovirology. 15(1):22.

Pinzone MRita, Graf E, Lynch L, McLaughlin B, Hecht FM, Connors M, Migueles SA, Hwang W-T, Nunnari G, O'Doherty U.  2016.  Monitoring Integration over Time Supports a Role for Cytotoxic T Lymphocytes and Ongoing Replication as Determinants of Reservoir Size.. J Virol. 90(23):10436-10445.